Tiziana Life Sciences
TLSA
21 hedge funds and large institutions have $513K invested in Tiziana Life Sciences in 2023 Q4 according to their latest regulatory filings, with 3 funds opening new positions, 6 increasing their positions, 1 reducing their positions, and 6 closing their positions.
500% more repeat investments, than reductions
Existing positions increased: 6 | Existing positions reduced: 1
0.13% more ownership
Funds ownership: 0.77% → 0.9% (+0.13%)
2% less capital invested
Capital invested by funds: $522K → $513K (-$9.03K)
13% less funds holding
Funds holding: 24 → 21 (-3)
50% less first-time investments, than exits
New positions opened: 3 | Existing positions closed: 6
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Morgan Stanley
New York
|
+$76.1K |
| 2 |
UBS Group
Zurich,
Switzerland
|
+$17.6K |
| 3 |
EL
EWA LLC
Pittsbugh,
Pennsylvania
|
+$9.46K |
| 4 |
TSS
Two Sigma Securities
New York
|
+$7.16K |
| 5 |
Credit Agricole
Montrouge Cedex,
France
|
+$6.31K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
HSBC Holdings
London,
United Kingdom
|
-$12.6K |
| 2 |
BFG
Bleakley Financial Group
Fairfield,
New Jersey
|
-$11.2K |
| 3 |
SS
Simplicity Solutions
Minneapolis,
Minnesota
|
-$11.2K |
| 4 |
XT
XTX Topco
George Town,
Cayman Islands
|
-$7.24K |
| 5 |
Osaic Holdings
Scottsdale,
Arizona
|
-$6.17K |
TLSA Hedge Fund Activity: Q4 2023 in Review
21 of the 6,860 institutional investors tracked by Wall St. Rank reported a position in Tiziana Life Sciences (TLSA) for Q4 2023, worth a combined $513K — down 1.7% from $522K a quarter earlier.
Sellers outnumbered buyers: 6 funds closed out of TLSA and 3 opened new positions — a net loss of 3 holders — while 1 trimmed existing stakes and 6 added.
The largest buyer was Morgan Stanley, adding an estimated $76.1K. The largest seller was HSBC Holdings, cutting an estimated $12.6K.
- 21 institutional investors held Tiziana Life Sciences (TLSA) as of Q4 2023, down from 24 in Q3 2023.
- Funds reported $513K of Tiziana Life Sciences stock for Q4 2023, down 1.7% quarter-over-quarter.
- 3 funds opened new Tiziana Life Sciences positions in Q4 2023 and 6 closed out, a net change of -3 holders.
- The largest Tiziana Life Sciences buyer in Q4 2023 was Morgan Stanley, an estimated $76.1K added.
- The largest Tiziana Life Sciences seller in Q4 2023 was HSBC Holdings, an estimated $12.6K sold.
Based on aggregated 13F filings for Q4 2023.